A sound preclinical study demonstrating in vitro and in vivo proof-of-concept for a novel CAR T approach targeting an intracellular antigen across diverse HLA alleles, but without clinical efficacy data or human trial results.
This is a summary/editorial commentary on another study, not a primary research report; the source does not provide original data, effect sizes, confidence intervals, p-values, or sample descriptions needed to grade the evidence.
This is an editorial commentary describing a resource paper, not a primary research study reporting empirical findings, effect sizes, or clinical outcomes to evaluate.